Introduction
In patients suspected of stable coronary artery disease (CAD) with low-intermediate pre-test risk of significant coronary stenosis guidelines recommend non-invasive ischaemia testing as gatekeeper to invasive coronary angiography (ICA), whereas patients with high pretest probability may be referred directly to ICA. 1 Numerous studies have shown that non-invasive ischaemia testing has a low accuracy in identifying patients with obstructive CAD resulting in low diagnostic yield of ICA. Coronary computed tomography angiography (CTA) is accurate in excluding CAD, 6 and absence of CAD by coronary CTA is associated with an excellent prognosis. [7] [8] [9] Guidelines recommend coronary CTA as an alternative to standard non-invasive ischaemia testing in symptomatic stable patients with low-intermediate pre-test probability of obstructive CAD. 1 However, coronary CTA is of modest value in quantifying stenosis severity, especially in the presence of coronary calcification, 10 and the correlation of stenosis to downstream ischaemia is poor. 11 Therefore, in symptomatic patients with suspected obstructive CAD determined by coronary CTA, guidelines recommend additional ischaemia testing before referral of patients to ICA. 1 Fractional flow reserve (FFR) derived by standard acquired coronary CTA (FFR CT ) enables computational assessment of coronary blood flow and pressure. 12 FFR CT has high diagnostic performance, [13] [14] [15] also in patients with high calcific burden, 16 and, since the FFR CT model incorporates the microcirculatory resistance, 12 in patients at high risk of having microvascular disease. 17 Recently, the technology has advanced beyond diagnostic validation into clinical utility. [18] [19] [20] Although promising, the real-world clinical utility of coronary CTA and FFR CT testing in stable patients with high risk of obstructive CAD is unknown. The purpose of this study was two-fold: In stable patients with typical angina pectoris to assess (i) Influence on the use of downstream ICA, and (ii) short-term safety of frontline coronary CTA with selective FFR CT testing.
Methods

Study population
All symptomatic patients referred to non-emergent frontline ICA 
Coronary CT angiography and FFR CT assessment
Coronary CTA was performed on Siemens SOMATOM Definition Flash and SOMATOM Force scanners (Siemens, Forchheim, Germany). The strategy of coronary CTA acquisition in this institution has previously been described. 19 In brief, all patients received 0.8 mg sublingual nitrates and oral/intravenous beta-blockers or oral ivabradine targeting a heart rate <60 beats per minute. An initial 120 kV non-enhanced high-pitch spiral acquisition was performed for calcium scoring. Coronary CTA was performed with prospective electrocardiographic triggering. Experienced cardiologists evaluated vessels > _2 mm in diameter using axial images and multi-planar reconstructions. 19 Local recommendations for downstream management of patients after coronary CTA and FFR CT testing are shown in Table 1 . FFR CT analysis was based on standard coronary CTA datasets (HeartFlow Inc., Redwood City, CA, USA). 15 The principles underlying FFR CT computation have been described previously. 12 FFR CT values distally in the major epicardial coronary arteries (including side branches) > _2 mm in diameter were registered and FFR CT values < _0.8 were considered diagnostic of lesion-specific ischaemia. 19 For clinical decision-making on FFR CT Computed tomography derived fractional flow reserve testing Figure 1 Diagnostic work-up of patients. N = numbers of patients. Numbers refer to planned diagnostic activities within 3 months after the initial coronary CTA. Inconclusive coronary CTAs were due to obesity (n = 2), irregular heart rhythm (n = 6), high Agatston (n = 0), lack of cooperation (n = 4), or combinations hereof (n = 12). CTA, CT angiography; ICA, invasive coronary angiography; OMT, optimal medical treatment; FFR CT , prescribed coronary CTA derived fractional flow reserve; MPI, myocardial perfusion imaging. protocols. Instantaneous wave-free ratio (iFR) was measured in few patients. 19 Decision on revascularization was at the discretion of the interventional cardiologist and experienced cardio-thoracic surgeons.
Radiation exposure
Radiation exposure is reported in mSv using conversion factors of 0.014 mSv/mGy-cm for coronary CTA (including calcium scans), 0. 
Results
A total of 795 consecutive patients were referred for ICA or coronary CTA testing during the study period. Twenty-one patients did not enter the study due to atrial fibrillation (n = 14), high BMI (n = 5), and renal insufficiency (n = 2). Thus, the study cohort comprised 774 patients of whom 181 (24%) had typical angina pectoris and thus constituted the high-risk group. Table 4) .
In the high-risk group, 28 (15%) patients were referred directly to ICA. Baseline characteristics of this group are presented in Supplementary data online, Table S1 . Coronary CTA was performed in 745 (96%) patients. The coronary CTA result was conclusive in 147 (96%) and 574 (97%) in the high-and low-intermediate-risk groups, respectively. Figure 1 shows the diagnostic flow in the two groups. 212 (28%) patients were prescribed FFR CT testing with a conclusive test result obtained in 72 (97%) and 137 (99%) in the high-and low-intermediate-risk patients, respectively. FFR CT testing was more frequent, and more patients were referred to ICA in high-than in low-intermediate-risk patients, 41% (74/181) vs. 23% (138/593) (P < 0.001), and 36% (66/181) vs. 9% (53/593) (P < 0.001), respectively. During the study period, seven patients underwent downstream MPI due to an inconclusive coronary CTA result (n = 3), as supplement to ICA (n = 3) or a positive FFR CT result (n = 1). The impact of coronary CTA and FFR CT testing on cancellation of ICA is shown in Figure 2 . Overall, in high-risk patients having coronary CTA performed, ICA was cancelled in 75% (115/153). Overall the effect of FFR CT testing on cancellation of ICA was higher in high-as compared with lowintermediate-risk patients. FFR CT was used as supplement to planned ICA in 35 patients. In 34 of these patients FFR CT analysis was conclusive with positive or negative FFR CT result in 28 and 6 patients, respectively. In these patients FFR/iFR interrogations were performed in 21% (6/28) and 67% (4/6) (P < 0.05), respectively. Figure 3 shows clinical examples of the impact of FFR CT testing on the referral to ICA.
Downstream test utilization
Coronary revascularization
Figures 4 and 5 provide overviews of the effect of FFR CT testing on the downstream use of planned ICA, FFR/iFR, and revascularization. Coronary revascularization was performed in 54% (64/119) of the patients (PCI, 61%; CABG, 39%). In patients with typical angina pectoris the rate of revascularization was higher in patients referred for coronary CTA as compared with patients being referred directly to ICA. Figure 6 shows the impact of coronary CTA and FFR CT testing on rates 
Clinical adverse events
Mean (SD) follow-up time was 157 (50) days. Clinical adverse events are presented in Table 5 . Serious clinical events occurred in four patients. None of the patients where ICA was cancelled due to the results of coronary CTA with selective FFR CT testing experienced serious clinical events.
Discussion
In this single-centre all-comer cohort study, frontline coronary CTA with selective FFR CT testing in stable, symptomatic patients with typical angina pectoris was feasible, and associated with a high rate of cancellation of scheduled ICAs. No serious adverse clinical events occurred in high-risk patients in whom ICA was cancelled within 90 days of follow-up.
An effective non-invasive test in stable CAD identifies patients who benefit from ICA, and provides guidance for subsequent patient care. Coronary CTA is increasingly used in patients suspected of stable CAD. However, the inverse relationship between increasing pre-test probability of CAD and the diagnostic specificity of coronary CTA should be acknowledged. 22 Moreover, the diagnostic specificity of coronary CTA declines with increasing calcium scores. 10 Consequently, guidelines do not recommend coronary CTA testing in patients with high pre-test probability of CAD or in the event of a high coronary calcium score. 1 In prospective multi-centre trials including patients with lowintermediate pre-test probability of stable CAD with blinded comparison to FFR, FFR CT showed high and, when compared with anatomical interpretation by coronary CTA alone, superior diagnostic specificity. [13] [14] [15] Moreover, FFR CT has improved diagnostic specificity beyond coronary CTA alone in patients with high coronary calcification. 16 In the PLATFORM study, in patients with planned ICA, FFR CT testing resulted in safe cancellation of ICA in 61% of the patients when compared with standard practice. 18 The present study extends previous findings by demonstrating that in a real-world large consecutive cohort of symptomatic patients with suspected CAD, evaluation with coronary CTA and selective FFR CT testing results in a high rate of cancellation of planned ICA irrespective of level of risk of CAD. Notably, pre-test risk of CAD by the Diamond-Forrester algorithm in our Numbers of adverse events (%). In the low-intermediate-risk group one non-ST-elevation myocardial infarction and two non-cardiac deaths occurred (known terminal cancer before referral and trauma, respectively). In the high-risk group one cardiac death occurred (refractory cardiac arrest within 24 h after coronary artery bypass surgery). The remaining 10 clinical adverse events did not result in testing or treatment. Guidelines for coronary revascularization support anatomic stenosis evaluation by ICA with FFR or conventional ischaemia testing. 1 In current practice less than two-thirds of patients undergo non-invasive ischaemia testing before ICA and the majority of patients have no angiographic evidence of obstructive CAD. 2, 4 Opposite to conventional ischaemia testing, FFR is a validated tool for the functional assessment on a per-lesion basis, which is needed to guide revascularization. However, the adoption of FFR in clinical practice is limited. 24 In the present study, the majority of revascularizations were performed with available information on lesion-specific ischaemia. Of note, the majority of functional tests were FFR CT , which in this institution has been adopted into clinical practice for revascularization guidance. 19 These findings are in accordance with the PLATFORM study in which data regarding the functional significance of coronary stenosis at the time of revascularization were available in 95% in the FFR CT guidance group compared with 49% in the usual care group. 18 In this institution FFR CT is used as a diagnostic gatekeeper to ICA or as a supplemental test in patients with multiple lesions in whom referral to ICA has been decided. Interestingly, a supplemental negative FFR CT result prompted use of FFR/iFR more frequently than when a positive FFR CT was present. This probably relates to the severity of CAD in these patients. Thus, in patients with positive FFR CT results the severity of CAD was high and the need of additional per-lesion functional information for guidance of revascularization was less than in patients with normal dichotomized FFR CT results.
Limitations
This is an observational and single-centre study and thus with inherent limitations. Specifically, it should be acknowledged that the criteria used in this study to define high risk anatomy and clinical recommendations following FFR CT testing have not been tested in randomized studies. However, our study included a large consecutive cohort of patients with limited exclusion criteria, and represent patients encountered in clinical practice. An extended follow-up including systematic registration of angina symptoms, which is the major target of PCI, would have added valuable information. High-risk was defined according to local practice as typical angina. This strategy was legitimized by previous findings showing that the presence of typical angina is a very strong predictor of finding obstructive CAD at ICA. 5 Moreover, the findings of a high baseline risk profile, high DiamondForrester score (67% vs. 31%), high calcium score (320 vs. 120) and a high revascularization rate (76% vs. 52%) in patients with vs. those without typical angina support this strategy. Local recommendations were not followed in all patients, thus 29 (4%) patients went directly to ICA and out of 511 patients who were prescribed OMT, 5 (1%) had coronary stenosis >50%. We did not record plaque composition, hence the potential value of this in terms of risk reclassification could not be elucidated. 25 
Conclusion
Frontline coronary CTA with selective FFR CT testing in stable, symptomatic patients with typical angina pectoris is associated with a high rate of cancellation of planned ICAs. The results obtained in this study need confirmation in larger randomized studies with longer follow-up.
Supplementary data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
